SI1502587T1 - Formulacija z zadrzevanim sproscanjem za Venlafaxin hidroklorid - Google Patents

Formulacija z zadrzevanim sproscanjem za Venlafaxin hidroklorid

Info

Publication number
SI1502587T1
SI1502587T1 SI200330541T SI200330541T SI1502587T1 SI 1502587 T1 SI1502587 T1 SI 1502587T1 SI 200330541 T SI200330541 T SI 200330541T SI 200330541 T SI200330541 T SI 200330541T SI 1502587 T1 SI1502587 T1 SI 1502587T1
Authority
SI
Slovenia
Prior art keywords
drug
sustained release
formulation
functional
drug substance
Prior art date
Application number
SI200330541T
Other languages
English (en)
Inventor
Evangelos Karavas
Konstantinos Lioumis
Stavros Politis
Original Assignee
Pharmathen Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmathen Sa filed Critical Pharmathen Sa
Publication of SI1502587T1 publication Critical patent/SI1502587T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI200330541T 2003-07-30 2003-07-30 Formulacija z zadrzevanim sproscanjem za Venlafaxin hidroklorid SI1502587T1 (sl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03386019A EP1502587B1 (en) 2003-07-30 2003-07-30 Sustained release formulation for Venlafaxine hydrochloride

Publications (1)

Publication Number Publication Date
SI1502587T1 true SI1502587T1 (sl) 2007-02-28

Family

ID=33522496

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200330541T SI1502587T1 (sl) 2003-07-30 2003-07-30 Formulacija z zadrzevanim sproscanjem za Venlafaxin hidroklorid

Country Status (15)

Country Link
US (2) US20060182797A1 (sl)
EP (1) EP1502587B1 (sl)
AT (1) ATE336988T1 (sl)
AU (1) AU2004258732B2 (sl)
BR (1) BRPI0412354A (sl)
CA (1) CA2529393C (sl)
CY (1) CY1107576T1 (sl)
DE (1) DE60307819T2 (sl)
DK (1) DK1502587T3 (sl)
ES (1) ES2271514T3 (sl)
PL (1) PL207998B1 (sl)
PT (1) PT1502587E (sl)
SI (1) SI1502587T1 (sl)
WO (1) WO2005009414A1 (sl)
ZA (1) ZA200600790B (sl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL146462A (en) * 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
WO2004047718A2 (en) * 2002-11-28 2004-06-10 Themis Laboratories Private Limited Process for manufacturing sustained release microbeads containing venlafaxine hci
WO2005048979A2 (en) * 2003-10-06 2005-06-02 Torrent Pharmaceuticals Limited Pharmaceutical composition having casing with multiple micro tablets
RU2340331C2 (ru) * 2004-02-04 2008-12-10 Алембик Лимитед Форма пролонгированного высвобождения венлафаксина гидрохлорида
WO2006136927A1 (en) * 2005-06-22 2006-12-28 Glenmark Pharmaceuticals Limited Extended release formulations comprising venlafaxine
US8920837B2 (en) * 2005-07-01 2014-12-30 Rubicon Research Private Limited Sustained release dosage form
US7427414B2 (en) * 2006-01-18 2008-09-23 Astron Research Limited Modified release oral dosage form using co-polymer of polyvinyl acetate
US20090175934A1 (en) * 2006-03-08 2009-07-09 Jubilant Organosys Ltd. Extended Release Pharmaceutical Formulation of Venlafaxine and Method of Manufacturing the Same
WO2007112574A1 (en) * 2006-04-03 2007-10-11 Isa Odidi Extended release composition of venlafaxine
JP5826456B2 (ja) 2006-04-26 2015-12-02 アルファファーム ピーティーワイ リミテッド コーティングされていない分離したユニットおよび延長放出マトリクスを含む制御放出配合物
WO2008140461A1 (en) * 2007-05-16 2008-11-20 Fmc Corporation Solid form
WO2009049354A1 (en) * 2007-10-16 2009-04-23 Alphapharm Pty Ltd Controlled-release pharmaceutical formulation
EP2403487A2 (en) * 2009-03-04 2012-01-11 Fdc Limited Oral controlled release dosage forms for water soluble drugs
US20130004563A1 (en) * 2011-06-07 2013-01-03 Shah Syed Multiparticulate s-adenosylmethionine compositions and related methods
CN103948557A (zh) * 2014-04-08 2014-07-30 闻晓光 一种新型控释片

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274171B1 (en) * 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
PE57198A1 (es) 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
UA77145C2 (en) * 1997-11-05 2006-11-15 Wyeth Corp Extended release dosage formulation
AU782059B2 (en) 1999-05-20 2005-06-30 Elan Pharma International Limited Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
BR0100334A (pt) 2001-01-17 2002-09-24 Diffucap Chemobras Quimica E F Processo para a preparação de composições de liberação programada contendo venlafaxina e o produto resultante
AU2002248792B2 (en) * 2001-04-18 2006-09-21 Nostrum Pharmaceuticals Inc. A novel coating for a sustained release pharmaceutical composition
WO2003013480A1 (en) * 2001-08-06 2003-02-20 Dr. Reddy's Laboratories Ltd. Improved enteric formulation of fluoxetin
US6696496B2 (en) * 2002-03-28 2004-02-24 Synthon Bv Low water-soluble venlafaxine salts

Also Published As

Publication number Publication date
PL379465A1 (pl) 2006-09-18
CA2529393C (en) 2010-08-17
DE60307819T2 (de) 2007-10-04
DK1502587T3 (da) 2007-01-02
EP1502587B1 (en) 2006-08-23
BRPI0412354A (pt) 2006-09-05
EP1502587A1 (en) 2005-02-02
CA2529393A1 (en) 2005-02-03
CY1107576T1 (el) 2013-03-13
ES2271514T3 (es) 2007-04-16
DE60307819D1 (de) 2006-10-05
PL207998B1 (pl) 2011-02-28
US20110171297A1 (en) 2011-07-14
US20060182797A1 (en) 2006-08-17
WO2005009414A1 (en) 2005-02-03
AU2004258732B2 (en) 2009-06-11
PT1502587E (pt) 2007-01-31
AU2004258732A1 (en) 2005-02-03
ATE336988T1 (de) 2006-09-15
ZA200600790B (en) 2007-04-25

Similar Documents

Publication Publication Date Title
CY1107576T1 (el) Ταχεια αποδεσμευση των υδατοδιαλυτων φαρμακευτικων ουσιων
AP1748A (en) Chronotherapeutic dosage forms.
WO2004026262A3 (en) Abuse-resistant pharmaceutical compositions
WO2004012699A3 (en) Modified release composition comprising coated micro matrix particles containing the high soluble active ingredient and a release controlling agent
WO2002028376A3 (en) Chrono delivery formulations and method of use thereof
WO2007103557A3 (en) Coating capsules with active pharmaceutical ingredients
CA2417686A1 (en) Manufacture of oral dosage forms delivering both immediate release and sustained release drugs
HUP0203451A2 (hu) Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra
HUP0301887A2 (hu) Több részecskébżl álló gyógyszerforma, amely legalább két különbözżen bevont pelletformát tartalmaz
HUP0003405A2 (hu) Szabályozott hatóanyag-leadású, szublingvális vagy bukkális adagolású gyógyszerkészítmények
AU5680100A (en) Controlled release and taste masking oral pharmaceutical compositions
WO2005027843A3 (en) Chronotherapeutic dosage forms
JP2008543936A5 (sl)
EP2397122A3 (en) Formulations of neramexane dosage forms
CA2352211A1 (en) Sustained release matrix systems for highly soluble drugs
CA2453263A1 (en) Pharmaceutical compositions containing terbinafine and use thereof
ES2185452A1 (es) Composicion farmaceutica de fluoxetina en comprimido dispersable recubierto y su proceso de fabricacion.
HK1060691A1 (en) Ion-strength independent sustained release pharmaceutical formulation
NZ270748A (en) Sustained release dosage form of alfuzosin hydrochloride coated with a ph-dissolution dependent polymer
WO2005115346A3 (en) Pharmaceutical composition containing risperidone
IL179177A (en) A pharmaceutical product including acyclovir and delivery compound, dosage unit, use of acyclovir in the preparation of the pharmaceutical product, use of the pharmaceutical product in the preparation of a drug and a method for the preparation of the pharmaceutical product
CA2516327A1 (en) Therapeutic system comprising amoxicillin and clavulanic acid
WO2003045305A3 (en) Acetaminophen compositions
WO2009014372A3 (en) Dispersible tablet comprising coated drug-containing particles and method for the preparation thereof
WO2002062299A3 (en) Improved controlled release oral dosage form